Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2021
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism
Aliya A Khan, Lars Rejnmark, Mishaela Rubin, et al.
Hormone Research in Paediatrics
|
March 6, 2025
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Aristides K Maniatis, Paul S Thornton, Ulhas M Nadgir, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2021
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 20, 2025
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results
Beverly M K Biller, Aleksandra Gilis-Januszewska, Mirjana Doknic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
JAMA Pediatrics
|
November 17, 2025
Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial
Ravi Savarirayan, Ciara McDonnell, Carlos A Bacino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
Aliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Advances in Therapy
|
May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2022
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Aristides K Maniatis, Samuel J Casella, Ulhas M Nadgir, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Endocrinology and Metabolism
|
August 4, 2021
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism
Aliya A Khan, Lars Rejnmark, Mishaela Rubin, et al.
Hormone Research in Paediatrics
|
March 6, 2025
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Aristides K Maniatis, Paul S Thornton, Ulhas M Nadgir, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2021
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial"
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 20, 2025
Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results
Beverly M K Biller, Aleksandra Gilis-Januszewska, Mirjana Doknic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 8, 2024
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial
Bart L Clarke, Aliya A Khan, Mishaela R Rubin, et al.
JAMA Pediatrics
|
November 17, 2025
Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial
Ravi Savarirayan, Ciara McDonnell, Carlos A Bacino, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
Aliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Advances in Therapy
|
May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2022
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Aristides K Maniatis, Samuel J Casella, Ulhas M Nadgir, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Page
of 12